Accelerated rTMS vs. Sham for Stroke Apathy

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 8, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
ApathyStrokeStroke SequelaeStroke/Brain AttackStroke/ Cerebrovascular Accident (Ischemic or Hemorrhagic)MotivationAbulia
Interventions
DEVICE

MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Active)

Active treatment will consist of high-dose iTBS-rTMS to left dmPFC delivered in runs of 600 pulses at an intensity of 120% resting motor threshold (rMT). iTBS triplets at 50 Hz will be delivered for 2 seconds, repeated every 10 seconds for a total of 190 seconds. Each session will be separated by at least 10-15 minutes and a total of 12 sessions will be given on each treatment day (3-4 hours per study day). A total of 43,200 pulses will be delivered over the entire six days of treatment.

DEVICE

MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Sham)

"For the sham stimulation group, a focal electric sham will be used which is indistinguishable from active TMS including a pretreatment individualized sham titration, sham outputs noises synchronized to pulse delivery, and an individualized level of sham stimulation throughout the treatment.~Technicians administering active vs sham TMS will be masked by using a random code generated by the statistician that will indicate whether to use the active or sham side of the coil. Treatments will appear identical to the technician regardless of whether active or sham TMS is administered."

OTHER

Brainsight Neuronavigation System

A brainsight neuronavigation system will be used during TMS treatments to target treatment location using individual MRI data

Trial Locations (1)

29403

RECRUITING

Medical University of South Carolina Brain Stimulation Lab, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT07113067 - Accelerated rTMS vs. Sham for Stroke Apathy | Biotech Hunter | Biotech Hunter